SMAD2 and cancer: The findings showed that deletion of VEGFA resulted in increased expression of PTEN, an inhibitor of pathways that promote cancer, as well as decreased expression of the members (MEK1/2 and AKT) of MAPK and the member (SMAD2) of TGFβ signaling pathways [16].